Fig. 3From: Advanced assessment of migration and invasion of cancer cells in response to mifepristone therapy using double fluorescence cytochemical labelingMifepristone reduces the migration of cancer cells of the ovary (a, b), breast (c), glia (d), or prostate (e) in a wound healing assay using fluorescent stains. Each cell line was treated with their respective concentration of MF for 72 h prior to wounding. Multiple images were taken of each wound, and the average wound width was calculated at 0 and 24 h. The width of the wound was measured four times per image. (b) Is a visual representation of SKOV-3 cells in a wound healing assay, labeled with Alexa Fluor®-594 Phalloidin and DAPI, to stain the cytoskeleton and nucleus respectively. Scale bar = 1000 μm. Data in a, c, d, and e represent the mean ± s.e.m. Vehicle (closed bars); MF (open bars). *P < 0.05, **P < 0.01, ***P < 0.001 compared against vehicle. Statistical analysis was done using two-way ANOVA followed by Bonferroni’s multiple-comparison testBack to article page